Mesenchymal Stem Cells for Cardiac Therapy: Practical Challenges and Potential Mechanisms (original) (raw)

References

  1. Pittenger, M. F., Mackay, A. M., Beck, S. C., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143–147.
    Article CAS PubMed Google Scholar
  2. Song, L., & Tuan, R. S. (2004). Transdifferentiation potential of human mesenchymal stem cells derived from bone marrow. The FASEB Journal, 18, 980–982.
    CAS Google Scholar
  3. Jiang, Y., Jahagirdar, B. N., Reinhardt, R. L., et al. (2002). Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 418, 41–49.
    Article CAS PubMed Google Scholar
  4. Hare, J. M., Traverse, J. H., Henry, T. D., et al. (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. Journal of the American College of Cardiology, 54, 2277–2286.
    Article CAS PubMed Google Scholar
  5. Li, Y., Yao, Y., Sheng, Z., Yang, Y., & Ma, G. (2011). Dual-modal tracking of transplanted mesenchymal stem cells after myocardial infarction. International Journal of Nanomedicine, 6, 815–823.
    Article CAS PubMed Google Scholar
  6. Williams, A. R., Trachtenberg, B., Velazquez, D. L., et al. (2011). Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circulation Research, 108, 792–796.
    Article CAS PubMed Google Scholar
  7. Quevedo, H. C., Hatzistergos, K. E., Oskouei, B. N., et al. (2009). Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proceedings of the National Academy of Sciences of the United States of America, 106, 14022–14027.
    Article CAS PubMed Google Scholar
  8. Amado, L. C., Saliaris, A. P., Schuleri, K. H., et al. (2005). Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proceedings of the National Academy of Sciences of the United States of America, 102, 11474–11479.
    Article CAS PubMed Google Scholar
  9. Miyahara, Y., Nagaya, N., Kataoka, M., et al. (2006). Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nature Medicine, 12, 459–465.
    Article CAS PubMed Google Scholar
  10. Koninckx, R., Hensen, K., Daniëls, A., et al. (2009). Human bone marrow stem cells co-cultured with neonatal rat cardiomyocytes display limited cardiomyogenic plasticity. Cytotherapy, 11, 778–792.
    Article CAS PubMed Google Scholar
  11. Ranganath, S. H., Levy, O., Inamdar, M. S., & Karp, J. M. (2012). Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell, 10, 244–258.
    Article CAS PubMed Google Scholar
  12. Friis, T., Haack-Sørensen, M., Mathiasen, A. B., et al. (2011). Mesenchymal stromal cell derived endothelial progenitor treatment in patients with refractory angina. Scandinavian Cardiovascular Journal, 45, 161–168.
    Article PubMed Google Scholar
  13. Penn, M. S., Ellis, S., Gandhi, S., et al. (2012). Adventitial delivery of an allogeneic bone marrow-derived adherent stem cell in acute myocardial infarction: phase I clinical study. Circulation Research, 110, 304–311.
    Article CAS PubMed Google Scholar
  14. Lunde, K., Solheim, S., Aakhus, S., et al. (2006). Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. The New England Journal of Medicine, 355, 1199–1209.
    Article CAS PubMed Google Scholar
  15. Wollert, K. C., Meyer, G. P., Lotz, J., et al. (2004). Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. Lancet, 364, 141–148.
    Article PubMed Google Scholar
  16. Schaefer, A., Zwadlo, C., Fuchs, M., et al. (2010). Long-term effects of intracoronary bone marrow cell transfer on diastolic function in patients after acute myocardial infarction: 5-year results from the randomized-controlled BOOST trial–an echocardiographic study. European Journal of Echocardiography, 11, 165–171.
    Article PubMed Google Scholar
  17. Meyer, G. P., Wollert, K. C., Lotz, J., et al. (2009). Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. European Heart Journal, 30, 2978–2984.
    Article PubMed Google Scholar
  18. Meyer, G. P., Wollert, K. C., Lotz, J., et al. (2006). Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months’ follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial. Circulation, 113, 1287–1294.
    Article PubMed Google Scholar
  19. Dai, W., Hale, S. L., Martin, B. J., et al. (2005). Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects. Circulation, 112, 214–223.
    Article PubMed Google Scholar
  20. Wen, Y., Meng, L., Xie, J., & Ouyang, J. (2011). Direct autologous bone marrow-derived stem cell transplantation for ischemic heart disease: a meta-analysis. Expert Opinion on Biological Therapy, 11, 559–567.
    Article PubMed Google Scholar
  21. Dominici, M., Le Blanc, K., Mueller, I., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315–317.
    Article CAS PubMed Google Scholar
  22. Acquistapace, A., Bru, T., Lesault, P.-F., et al. (2011). Human mesenchymal stem cells reprogram adult cardiomyocytes toward a progenitor-like state through partial cell fusion and mitochondria transfer. Stem Cells, 29, 812–824.
    Article CAS PubMed Google Scholar
  23. Gaebel, R., Furlani, D., Sorg, H., et al. (2011). Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PloS One, 6, e15652.
    Article CAS PubMed Google Scholar
  24. Bayes-Genis, A., Soler-Botija, C., Farré, J., et al. (2010). Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. Journal of Molecular and Cellular Cardiology, 49, 771–780.
    Article CAS PubMed Google Scholar
  25. Zhao, Z., Chen, Z., Zhao, X., et al. (2011). Sphingosine-1-phosphate promotes the differentiation of human umbilical cord mesenchymal stem cells into cardiomyocytes under the designated culturing conditions. Journal of Biomedical Science, 18, 37.
    Article CAS PubMed Google Scholar
  26. Zvaifler, N. J., Marinova-Mutafchieva, L., Adams, G., et al. (2000). Mesenchymal precursor cells in the blood of normal individuals. Arthritis Research, 2, 477–488.
    Article CAS PubMed Google Scholar
  27. Kurth, T. B., Dell’accio, F., Crouch, V., Augello, A., Sharpe, P. T., & De Bari, C. (2011). Functional mesenchymal stem cell niches in adult mouse knee joint synovium in vivo. Arthritis and Rheumatism, 63, 1289–1300.
    Article PubMed Google Scholar
  28. Tsuji, H., Miyoshi, S., Ikegami, Y., et al. (2010). Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circulation Research, 106, 1613–1623.
    Article CAS PubMed Google Scholar
  29. Sabatini, F., Petecchia, L., Tavian, M., Jodon de Villeroché, V., Rossi, G. A., & Brouty-Boyé, D. (2005). Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Laboratory Investigation, 85, 962–971.
    Article CAS PubMed Google Scholar
  30. Kawada, H., Fujita, J., Kinjo, K., et al. (2004). Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood, 104, 3581–3587.
    Article CAS PubMed Google Scholar
  31. Peister, A., Mellad, J. A., Larson, B. L., Hall, B. M., Gibson, L. F., & Prockop, D. J. (2004). Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood, 103, 1662–1668.
    Article CAS PubMed Google Scholar
  32. Bonios, M., Terrovitis, J., Chang, C. Y., et al. (2011). Myocardial substrate and route of administration determine acute cardiac retention and lung bio-distribution of cardiosphere-derived cells. Journal of Nuclear Cardiology, 18, 443–450.
    Article PubMed Google Scholar
  33. Dib, N., Khawaja, H., Varner, S., McCarthy, M., & Campbell, A. (2011). Cell therapy for cardiovascular disease: a comparison of methods of delivery. Journal of Cardiovascular Translational Research, 4, 177–181.
    Article PubMed Google Scholar
  34. Wei, F., Wang, T., Liu, J., Du, Y., & Ma, A. (2011). The subpopulation of mesenchymal stem cells that differentiate toward cardiomyocytes is cardiac progenitor cells. Experimental Cell Research, 317, 2661–2670.
    Article CAS PubMed Google Scholar
  35. Hatzistergos, K. E., Quevedo, H., Oskouei, B. N., et al. (2010). Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circulation Research, 107, 913–922.
    Article CAS PubMed Google Scholar
  36. Numasawa, Y., Kimura, T., Miyoshi, S., et al. (2011). Treatment of human mesenchymal stem cells with angiotensin receptor blocker improved efficiency of cardiomyogenic transdifferentiation and improved cardiac function via angiogenesis. Stem Cells, 29, 1405–1414.
    CAS PubMed Google Scholar
  37. Siegel. G., Krause, P., Wöhrle, S., et al. (2012). Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential. Stem Cells and Development, -not available-, ahead of print.
  38. Sassoli, C., Pini, A., Mazzanti, B., et al. (2011). Mesenchymal stromal cells affect cardiomyocyte growth through juxtacrine Notch-1/Jagged-1 signaling and paracrine mechanisms: clues for cardiac regeneration. Journal of Molecular and Cellular Cardiology, 51, 399–408.
    Article CAS PubMed Google Scholar
  39. Boni, A., Urbanek, K., Nascimbene, A., et al. (2008). Notch1 regulates the fate of cardiac progenitor cells. Proceedings of the National Academy of Sciences of the United States of America, 105, 15529–15534.
    Article CAS PubMed Google Scholar
  40. Abarbanell, A. M., Wang, Y., Herrmann, J. L., et al. (2010). Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury. American Journal of Physiology: Heart and Circulatory Physiology, 298, H1529–36.
    Article CAS PubMed Google Scholar
  41. Varoga, D., Paulsen, F., Mentlein, R., et al. (2006). TLR-2-mediated induction of vascular endothelial growth factor (VEGF) in cartilage in septic joint disease. Journal of Pathology, 210, 315–324.
    Article CAS PubMed Google Scholar
  42. Williams, A. R., & Hare, J. M. (2011). Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circulation Research, 109, 923–940.
    Article CAS PubMed Google Scholar
  43. Xu, H., Yang, Y.-J., Qian, H.-Y., Tang, Y.-D., Wang, H., & Zhang, Q. (2011). Rosuvastatin treatment activates JAK-STAT Pathway and increases efficacy of allogeneic mesenchymal stem cell transplantation in infarcted hearts. Circulation Journal, 75, 1476–1485.
    Article CAS PubMed Google Scholar
  44. Loffredo, F. S., Steinhauser, M. L., Gannon, J., & Lee, R. T. (2011). Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair. Cell Stem Cell, 8, 389–398.
    Article CAS PubMed Google Scholar
  45. Zisa, D., Shabbir, A., Suzuki, G., & Lee, T. (2009). Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair. Biochemical and Biophysical Research Communications, 390, 834–838.
    Article CAS PubMed Google Scholar
  46. Valiunas, V., Doronin, S., Valiuniene, L., et al. (2004). Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. The Journal of Physiology, 555, 617–626.
    Article CAS PubMed Google Scholar
  47. Mills, W. R., Mal, N., Kiedrowski, M. J., et al. (2007). Stem cell therapy enhances electrical viability in myocardial infarction. Journal of Molecular and Cellular Cardiology, 42, 304–314.
    Article CAS PubMed Google Scholar
  48. Serrao, G.S., Turnbull, I.C., Ancukiewicz, D., et al. (2012). Myocyte-Depleted Engineered Cardiac Tissue Support Therapeutic Potential of Mesenchymal Stem Cells. Tissue Engineering Part A, doi:10.1089/ten.TEA.2011.0278.
  49. Chang, M. G., Tung, L., Sekar, R. B., et al. (2006). Proarrhythmic potential of mesenchymal stem cell transplantation revealed in an in vitro coculture model. Circulation, 113, 1832–1841.
    Article PubMed Google Scholar
  50. Costa, A. R., Panda, N. C., Yong, S., et al. (2012). Optical mapping of cryoinjured rat myocardium grafted with mesenchymal stem cells. American Journal of Physiology: Heart and Circulatory Physiology, 302, H270–7.
    Article CAS PubMed Google Scholar
  51. Ramkisoensing, A. A., Pijnappels, D. A., Askar, S. F. A., et al. (2011). Human embryonic and fetal mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterparts. PloS One, 6, e24164.
    Article CAS PubMed Google Scholar
  52. Hwang, N. S., Kim, M. S., Sampattavanich, S., Baek, J. H., Zhang, Z., & Elisseeff, J. (2006). Effects of three-dimensional culture and growth factors on the chondrogenic differentiation of murine embryonic stem cells. Stem Cells, 24, 284–291.
    Article CAS PubMed Google Scholar
  53. Engler, A. J., Sen, S., Sweeney, H. L., & Discher, D. E. (2006). Matrix elasticity directs stem cell lineage specification. Cell, 126, 677–689.
    Article CAS PubMed Google Scholar
  54. Engler, A. J., Carag-Krieger, C., Johnson, C. P., et al. (2008). Embryonic cardiomyocytes beat best on a matrix with heart-like elasticity: scar-like rigidity inhibits beating. Journal of Cell Science, 121, 3794–3802.
    Article CAS PubMed Google Scholar
  55. Jacot, J. G., McCulloch, A. D., & Omens, J. H. (2008). Substrate stiffness affects the functional maturation of neonatal rat ventricular myocytes. Biophysical Journal, 95, 3479–3487.
    Article CAS PubMed Google Scholar
  56. Domian, I. J., Chiravuri, M., van der Meer, P., et al. (2009). Generation of functional ventricular heart muscle from mouse ventricular progenitor cells. Science, 326, 426–429.
    Article CAS PubMed Google Scholar
  57. Tulloch, N. L., Muskheli, V., Razumova, M. V., et al. (2011). Growth of engineered human myocardium with mechanical loading and vascular coculture. Circulation Research, 109, 47–59.
    Article CAS PubMed Google Scholar
  58. Schaaf, S., Shibamiya, A., Mewe, M., et al. (2011). Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology. PloS One, 6, e26397.
    Article CAS PubMed Google Scholar
  59. Chen, C.-H., Wei, H.-J., Lin, W.-W., et al. (2008). Porous tissue grafts sandwiched with multilayered mesenchymal stromal cell sheets induce tissue regeneration for cardiac repair. Cardiovascular Research, 80, 88–95.
    Article CAS PubMed Google Scholar
  60. Simpson, D. L., Boyd, N. L., Kaushal, S., Stice, S. L., & Dudley, S. C. (2012). Use of human embryonic stem cell derived-mesenchymal cells for cardiac repair. Biotechnology and Bioengineering, 109, 274–283.
    Article CAS PubMed Google Scholar

Download references